+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Pulmonary Valve System Market by Product Type (Surgically Implanted Pulmonary Valve, Transcatheter Pulmonary Valve), Material Type (Mechanical Valve, Polymer Valve, Tissue Valve), End User, Distribution Channel, Age Group - Global Forecast 2025-2030- Product Image
Artificial Pulmonary Valve System Market by Product Type (Surgically Implanted Pulmonary Valve, Transcatheter Pulmonary Valve), Material Type (Mechanical Valve, Polymer Valve, Tissue Valve), End User, Distribution Channel, Age Group - Global Forecast 2025-2030- Product Image
New

Artificial Pulmonary Valve System Market by Product Type (Surgically Implanted Pulmonary Valve, Transcatheter Pulmonary Valve), Material Type (Mechanical Valve, Polymer Valve, Tissue Valve), End User, Distribution Channel, Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6119443
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The artificial pulmonary valve system represents a critical advancement in cardiovascular therapy, bridging the gap between traditional open-heart surgery and minimally invasive treatments. These prosthetic devices are engineered to replicate the function of native pulmonary valves, restoring unidirectional blood flow from the right ventricle to the pulmonary artery. Over the past decade, device developers have harnessed novel biomaterials, refined hemodynamic profiles, and leveraged advanced imaging guidance to enhance procedural safety and long-term durability.

As patient populations diversify, with rising incidence of congenital heart defects in neonates and heart failure in adults, the demand for tailored valve solutions has accelerated. Surgical implantation methods have evolved alongside transcatheter delivery systems, broadening therapeutic options. The clinical community is now witnessing a paradigm shift toward value-driven care, emphasizing faster recovery, reduced hospitalization, and improved quality of life. Consequently, stakeholders across hospitals, specialized clinics, and ambulatory centers are adopting these systems to meet evolving patient expectations. This introduction lays the groundwork for an in-depth exploration of market dynamics, regulatory influences, segmentation factors, and strategic imperatives that will define the future of artificial pulmonary valve interventions.

Rapid Transformations Reshaping the Artificial Pulmonary Valve Landscape Driven by Technological Breakthroughs Patient Demographics and Regulatory Evolution

In response to growing clinical demand, the artificial pulmonary valve landscape has undergone rapid transformation driven by cutting-edge technological breakthroughs. New valve geometries and polymer composites are enhancing hemodynamic efficiency and minimizing thrombotic risk, while advanced catheter systems enable precise positioning through percutaneous access. Regulatory agencies are streamlining approval pathways for next-generation devices, accelerating time to market for minimally invasive transcatheter valves. At the same time, surgical techniques have been refined to reduce operative trauma and shorten postoperative recovery.

Shifting patient demographics, including an aging population with comorbidities and an expanding cohort of pediatric survivors of congenital heart procedures, further underscore the need for differentiated solutions. Value-based reimbursement models are prompting providers to prioritize devices that demonstrate cost-effectiveness alongside clinical efficacy. Digital health initiatives, such as remote monitoring and telemetric valve performance tracking, are emerging as adjuncts to traditional care pathways. These transformative shifts converge to create an environment where innovation, patient-centric design, and evidence-driven outcomes will dictate competitive advantage.

Assessing the Consequences of 2025 United States Tariffs on Artificial Pulmonary Valve Systems Impacting Supply Chains Costs and Market Dynamics

The implementation of new United States tariffs in 2025 is reshaping the economic framework for artificial pulmonary valve manufacturers and suppliers. With import duties impacting critical components and raw materials, cost pressures have intensified across the supply chain. Device producers are evaluating strategies such as localized manufacturing, strategic stockpiling, and renegotiated supplier contracts to mitigate the financial burden. Health systems and payers are responding by scrutinizing procurement processes, seeking volume-based agreements and bundled payment structures to maintain affordability.

These tariff adjustments are also prompting a realignment of global sourcing networks. Manufacturers are diversifying their supplier base to reduce reliance on high-tariff regions, while forging partnerships with domestic foundries and contract manufacturing organizations. Investment decisions are increasingly influenced by the need for supply chain resilience, even if it entails higher short-term capital expenditure. As a result, industry leaders must balance regulatory compliance, cost containment, and operational continuity to preserve patient access to life-saving valve technologies.

InDepth Segmentation Analysis Revealing How Product Types Materials End Users Distribution Channels and Age Groups Define Market Drivers

A detailed segmentation approach reveals the nuances that drive demand and shape innovation within the artificial pulmonary valve domain. Analysis by product type distinguishes surgically implanted pulmonary valves, comprising both bioprosthetic and mechanical variants, from transcatheter pulmonary valves, which include balloon-expandable and self-expandable designs. Each device category presents unique procedural requirements, durability profiles, and patient suitability criteria. Equally important, material type segmentation underscores the trade-offs between mechanical valves, such as bileaflet and tilting-disc configurations, and tissue-based solutions, including pericardial and porcine tissue constructs, as well as cutting-edge polymer composites.

End-user segmentation highlights adoption patterns across ambulatory surgical centers, hospitals, and specialty clinics, reflecting differences in procedural volume, infrastructure capabilities, and clinical expertise. Meanwhile, distribution channel analysis examines the balance between direct sales models, which afford manufacturers tighter control over pricing and customer engagement, and distributor networks that extend market reach and local support. Finally, demographic segmentation across age groups reveals a spectrum of clinical demands: adults-spanning geriatric, middle-aged, and young adult cohorts-require durability and hemodynamic efficiency, whereas pediatric populations, from neonatal to adolescent stages, demand precision sizing and biocompatibility to accommodate growth and developmental considerations.

Regional Dynamics Uncovered Highlighting the Unique Opportunities and Challenges across Americas Europe Middle East Africa and AsiaPacific Markets

Regional insights provide a strategic lens through which stakeholders can tailor market approaches and investment priorities. In the Americas, advanced reimbursement frameworks and robust research infrastructure have fostered early adoption of transcatheter pulmonary valves and ongoing clinical trials that push the boundaries of device innovation. The United States remains a pivotal hub for regulatory approvals and capital allocation, while Latin American markets exhibit growing interest in cost-effective surgical solutions.

Across Europe, the Middle East, and Africa, a heterogeneous landscape emerges. Western European nations benefit from established healthcare networks and fast-track regulatory pathways, whereas emerging economies in the Middle Eastern corridor are channeling investments into cardiovascular centers of excellence. In Africa, infrastructural limitations present both challenges and opportunities for philanthropic initiatives and public-private partnerships aimed at enhancing device accessibility. In the Asia-Pacific region, demographic shifts and increasing healthcare expenditures are driving demand for both surgical and transcatheter valve systems. Markets such as China, India, and Japan are prioritizing domestic manufacturing, regulatory alignment, and localized clinical trials to support long-term growth strategies.

Strategic Company Developments and Competitive Insights Spotlighting Innovation Partnerships and Leadership Movements Shaping the Artificial Pulmonary Valve Sector

Leading companies are actively shaping the future of artificial pulmonary valve systems through strategic collaborations, research and development investments, and tactical market expansions. Industry frontrunners are forging alliances with academic institutions and device innovators to accelerate next-generation polymer valve technologies and self-expanding transcatheter platforms. Concurrently, select manufacturers are pursuing mergers and acquisitions to broaden their product portfolios and penetrate underserved geographies.

Innovative clinical programs, including first-in-human trials and post-market surveillance initiatives, are informing iterative device enhancements. Strategic partnerships with digital health firms are introducing remote monitoring capabilities that capture real-world valve performance data. In parallel, companies are optimizing their customer support infrastructure, establishing training centers and simulation labs to upskill surgical teams. These competitive maneuvers underscore a shared focus on patient-centered design, regulatory agility, and operational excellence that will determine leadership in this specialized field.

Actionable Recommendations for Industry Leaders to Accelerate Growth Enhance Patient Outcomes Strengthen Supply Resilience and Leverage Technological Advances

Industry leaders are advised to cultivate hybrid portfolios that integrate both surgical and transcatheter pulmonary valve solutions. By investing in advanced catheter delivery systems alongside traditional surgical platforms, organizations can address diverse patient segments and procedural settings. To alleviate the impact of tariffs and supply chain fluctuations, establishing localized manufacturing capabilities or forging joint ventures with regional manufacturers will enhance resiliency and cost stability.

Engagement with payers and policy makers is essential for securing value-based reimbursement models that reward superior clinical outcomes. Leaders should also expand digital health initiatives, incorporating remote monitoring and telemetric device analytics to differentiate their offerings. Optimizing distribution strategies through a balanced approach between direct sales and third-party distributors can broaden market penetration while maintaining close customer relationships. Finally, fostering collaborations with pediatric and adult congenital heart care centers will inform design refinements and ensure device portfolios meet evolving clinical needs across age groups.

Rigorous Research Methodology Demonstrating How Data Collection Validation and Analysis Deliver Robust Insights into the Artificial Pulmonary Valve System Market

A rigorous research methodology underpins the generation of actionable insights and ensures the report’s credibility. Primary research comprised in-depth interviews with cardiothoracic surgeons, interventional cardiologists, procurement executives, and hospital administrators to capture first-hand perspectives on device usage, clinical outcomes, and purchasing criteria. Secondary research involved comprehensive reviews of peer-reviewed journals, regulatory filings, patent databases, and clinical trial registries to consolidate technical specifications and performance data.

Data validation was achieved through triangulation, cross-referencing quantitative findings with qualitative interviews and publicly available literature. An expert advisory panel provided continuous feedback on emerging trends and verification of critical assumptions. Advanced analytical frameworks, including SWOT analysis, Porter’s Five Forces, and competitive benchmarking, facilitated robust strategic interpretation. This multi-modal approach guarantees a balanced, reliable, and reproducible set of insights tailored to the artificial pulmonary valve ecosystem.

Conclusive Reflections on Key Findings and Emerging Trends Guiding Future Innovations and Strategic Decisions in the Artificial Pulmonary Valve System Field

The findings illuminate a dynamic environment where technological innovation, regulatory shifts, and demographic trends converge to redefine therapeutic paradigms for pulmonary valve disease. The expansion of transcatheter approaches complements established surgical techniques, while material science breakthroughs enhance valve durability and patient compatibility. Tariff-induced supply chain challenges underscore the need for localized manufacturing and strategic sourcing, whereas granular segmentation and regional insights reveal diverse adoption patterns across clinical settings and geographies.

Competitive intelligence highlights aggressive R&D investments, collaborative partnerships, and digital health integration as key differentiators. Actionable recommendations emphasize portfolio diversification, supply chain resiliency, and payer engagement to secure sustainable growth. Ultimately, stakeholders who align their strategies with the evolving landscape-prioritizing patient outcomes, cost-effectiveness, and evidence-based innovation-will be well-positioned to lead the next chapter in artificial pulmonary valve system development.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Product Type
    • Surgically Implanted Pulmonary Valve
      • Bioprosthetic Valve
      • Mechanical Valve
    • Transcatheter Pulmonary Valve
      • Balloon Expandable Valve
      • Self Expandable Valve
  • Material Type
    • Mechanical Valve
      • Bileaflet Valve
      • Tilting Disc Valve
    • Polymer Valve
    • Tissue Valve
      • Pericardial Tissue
      • Porcine Tissue
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Distribution Channel
    • Direct Sales
    • Distributor Sales
  • Age Group
    • Adult
      • Geriatric
      • Middle Aged
      • Young Adult
    • Pediatric
      • Adolescent
      • Infant
      • Neonatal
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • Medtronic plc
  • Edwards Lifesciences Corporation
  • Venus MedTech (Hangzhou) Co., Ltd.
  • LivaNova PLC
  • Boston Scientific Corporation
  • Biosensors International Group, Ltd.
  • Beijing Lepu Medical Technology Co., Ltd.
  • CryoLife, Inc.
  • MedAlliance SA
  • Taewoong Medical Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of transcatheter pulmonary valve implantation in pediatric patients with congenital defects
5.2. Integration of biodegradable polymer materials for enhanced durability and reduced thrombogenicity in pulmonary valves
5.3. Development of patient-specific 3d printed pulmonary valve scaffolds to optimize fit and minimize complications
5.4. Increasing collaboration between device manufacturers and academic institutions to accelerate pulmonary valve innovation
5.5. Expansion of minimally invasive catheter-based delivery systems for targeted pulmonary valve deployment in adult patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Pulmonary Valve System Market, by Product Type
8.1. Introduction
8.2. Surgically Implanted Pulmonary Valve
8.2.1. Bioprosthetic Valve
8.2.2. Mechanical Valve
8.3. Transcatheter Pulmonary Valve
8.3.1. Balloon Expandable Valve
8.3.2. Self Expandable Valve
9. Artificial Pulmonary Valve System Market, by Material Type
9.1. Introduction
9.2. Mechanical Valve
9.2.1. Bileaflet Valve
9.2.2. Tilting Disc Valve
9.3. Polymer Valve
9.4. Tissue Valve
9.4.1. Pericardial Tissue
9.4.2. Porcine Tissue
10. Artificial Pulmonary Valve System Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Artificial Pulmonary Valve System Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor Sales
12. Artificial Pulmonary Valve System Market, by Age Group
12.1. Introduction
12.2. Adult
12.2.1. Geriatric
12.2.2. Middle Aged
12.2.3. Young Adult
12.3. Pediatric
12.3.1. Adolescent
12.3.2. Infant
12.3.3. Neonatal
13. Americas Artificial Pulmonary Valve System Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Artificial Pulmonary Valve System Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Artificial Pulmonary Valve System Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. Edwards Lifesciences Corporation
16.3.3. Venus MedTech (Hangzhou) Co., Ltd.
16.3.4. LivaNova PLC
16.3.5. Boston Scientific Corporation
16.3.6. Biosensors International Group, Ltd.
16.3.7. Beijing Lepu Medical Technology Co., Ltd.
16.3.8. CryoLife, Inc.
16.3.9. MedAlliance SA
16.3.10. Taewoong Medical Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET: RESEARCHAI
FIGURE 26. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 27. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 28. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BIOPROSTHETIC VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BIOPROSTHETIC VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SELF EXPANDABLE VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SELF EXPANDABLE VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BILEAFLET VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BILEAFLET VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TILTING DISC VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TILTING DISC VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY POLYMER VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY POLYMER VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PERICARDIAL TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PERICARDIAL TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PORCINE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PORCINE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MIDDLE AGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY YOUNG ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY YOUNG ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 134. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 135. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 136. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 137. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 140. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 142. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 143. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 150. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 151. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 152. CANADA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 265. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 287. FRANCE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Pulmonary Valve System market report include:
  • Medtronic plc
  • Edwards Lifesciences Corporation
  • Venus MedTech (Hangzhou) Co., Ltd.
  • LivaNova PLC
  • Boston Scientific Corporation
  • Biosensors International Group, Ltd.
  • Beijing Lepu Medical Technology Co., Ltd.
  • CryoLife, Inc.
  • MedAlliance SA
  • Taewoong Medical Co., Ltd.

Related Topics

Related Reports

Transcatheter Pulmonary Valve Market by Technology, Raw Material, Application, End User, and Region 2025-2033 - Product Image

Transcatheter Pulmonary Valve Market by Technology, Raw Material, Application, End User, and Region 2025-2033

  • Report
  • 128 Pages
  • Global
From
Transcatheter Pulmonary Valve Market by Valve Type (Balloon Expandable Valve, Self Expanding Valve), Application (Combined Lesions, Pulmonary Regurgitation, Pulmonary Stenosis), End User - Global Forecast 2025-2030 - Product Image

Transcatheter Pulmonary Valve Market by Valve Type (Balloon Expandable Valve, Self Expanding Valve), Application (Combined Lesions, Pulmonary Regurgitation, Pulmonary Stenosis), End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report By Application (Pulmonary Stenosis, Pulmonary Regurgitation), By Technology, By End-use, By Raw Material, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report By Application (Pulmonary Stenosis, Pulmonary Regurgitation), By Technology, By End-use, By Raw Material, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Transcatheter Pulmonary Valve Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Transcatheter Pulmonary Valve Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From
Transcatheter Pulmonary Valves - Global Strategic Business Report - Product Image

Transcatheter Pulmonary Valves - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.